Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.04.28
第四届监事会第九次会议决议公告
2018.04.25
第四届董事会第十二次会议决议公告
2018.04.25
关于召开2017年度股东大会的通知公告
2018.04.25
2017年度内部控制自我评价报告
2018.04.25
内部控制审计报告
2018.04.25
关于公司募集资金年度存放与实际使用情况的鉴证报告
2018.04.25
第四届监事会第八次会议决议公告
2018.04.25
2017年度募集资金存放与使用情况的专项报告
2018.04.25
关于公司非经营性资金占用及其他关联往来情况汇总表的专项审核报告
2018.04.25
未来三年(2018-2020年)股东分红回报规划
第一页
上一页
54
55
56
57
58
下一页
最后一页